A61K 47/40
Cyclodextrins
Official title: Cyclodextrins; Derivatives thereof
A61K47/40 (Cyclodextrins) appears on 1,086 US grants and 2,133 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,086
- Published applications
- 2,133
- Assignees
- 969
- Inventors
- 3,598
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 10 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 12 | 0 |
| 2002 | 6 | 19 |
| 2003 | 15 | 33 |
| 2004 | 12 | 37 |
| 2005 | 13 | 41 |
| 2006 | 12 | 24 |
| 2007 | 14 | 53 |
| 2008 | 7 | 27 |
| 2009 | 4 | 43 |
| 2010 | 17 | 52 |
| 2011 | 8 | 43 |
| 2012 | 19 | 51 |
| 2013 | 23 | 60 |
| 2014 | 29 | 78 |
| 2015 | 43 | 72 |
| 2016 | 35 | 70 |
| 2017 | 53 | 102 |
| 2018 | 60 | 119 |
| 2019 | 81 | 158 |
| 2020 | 98 | 182 |
| 2021 | 95 | 168 |
| 2022 | 83 | 155 |
| 2023 | 86 | 155 |
| 2024 | 72 | 153 |
| 2025 | 87 | 112 |
| 2026 | 48 | 126 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical composition for controlled release of weak acid drugs and uses thereof29 Sep 2026US 12,746,200 B2Pharmosa Biopharm Inc.
- Transmucosal film for treating insomnia15 Sep 2026US 12,734,127 B1Xiamen LP Pharmaceutical Co., Ltd.
- Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and Cushing's syndrome8 Sep 2026US 12,728,103 B2
- Method and composition for an improved bioavailability delivery system1 Sep 2026US 12,721,814 B2Americana Pharma LLC
- Liposomal formulations comprising AT1 receptor blockers and uses thereof25 Aug 2026US 12,714,669 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Pharmaceutical compositions comprising meloxicam8 Oct 2026US 2026/0306635 A1Axsome Therapeutics, Inc.
- Technologies targeting cell states8 Oct 2026US 2026/0306640 A1Auron Therapeutics, Inc.
- Method for Medical Imaging1 Oct 2026US 2026/0294251 A1Integro Theranositcs, LLC
- Compositions containing retinoic esters having extended storage stability and cosmetic compositions containing the same1 Oct 2026US 2026/0294777 A1Grant Industries, Inc.
- Methods of treating central nervous system disorders with sublingual or buccal dosage forms comprising antioxidants1 Oct 2026US 2026/0294802 A1Beyond Barriers Therapeutics, Inc.
Most cited
By later US patents
- Formulation of a reconstituted protein, and method and kit for the production thereof234US 5,580,856 A1996
- Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations234US 6,046,177 ACydex, Inc. · 2000
- Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use212US 5,874,418 ACydex, Inc. · 1999
- Pharmaceutical composition and its nasal or vaginal use203US 4,659,696 ATakeda Chemical Industries, Ltd. · 1987
- Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof148US 6,133,248 ACydex, Inc. · 2000